2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk

Show full item record



Permalink

http://hdl.handle.net/10138/307445

Citation

Task Force Members , ESC Comm Practice Guidelines CPG , ESC Natl Cardiac Societies , Mach , F , Baigent , C & Taskinen , M-R 2019 , ' 2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk ' , Atherosclerosis , vol. 290 , pp. 140-205 . https://doi.org/10.1016/j.atherosclerosis.2019.08.014

Title: 2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk
Author: Task Force Members; ESC Comm Practice Guidelines CPG; ESC Natl Cardiac Societies; Mach, Francois; Baigent, Colin; Taskinen, Marja-Riitta
Contributor: University of Helsinki, HUS Heart and Lung Center
Date: 2019-11
Language: eng
Number of pages: 66
Belongs to series: Atherosclerosis
ISSN: 0021-9150
URI: http://hdl.handle.net/10138/307445
Subject: Guidelines
Dyslipidaemias
Cholesterol
Triglycerides
Low-density lipoproteins
High-density lipoproteins
Apolipoprotein B
Lipoprotein(a)
Lipoprotein remnants
Total cardiovascular risk
Treatment (lifestyle)
Treatment (drugs)
Treatment (adherence)
Very low-density lipoproteins
Familial hypercholesterolaemia
DENSITY-LIPOPROTEIN CHOLESTEROL
CORONARY-HEART-DISEASE
C-REACTIVE PROTEIN
HIGH-DOSE ATORVASTATIN
TYPE-2 DIABETES-MELLITUS
ALL-CAUSE MORTALITY
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
STATIN-TREATED PATIENTS
INTIMA-MEDIA THICKNESS
CHRONIC KIDNEY-DISEASE
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0021915019314595_main.pdf 5.765Mb PDF View/Open
main.pdf 300.8Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record